🎁 Black Friday: up to 50% off of annual plans
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
5.57
-0.29 (-4.95%)
At close: Nov 20, 2026, 4:00 PM EST
5.60
+0.03 (0.54%)
After-hours: Nov 20, 2026, 7:30 PM EST

Ocular Therapeutix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
50.3851.9563.7258.4451.4943.52
Revenue Growth
-9.68%-18.47%9.03%13.49%18.32%150.08%
Cost of Revenue
252.33203.67133.2666.345854.49
Gross Profit
-201.94-151.72-69.54-7.89-6.51-10.97
Selling, General & Admin
141.13118.391.3474.4972.1567.07
Operating Expenses
141.13118.391.3474.4972.1567.07
Operating Income
-343.07-270.02-160.88-82.38-78.65-78.04
Interest Expense
-11.22-11.84-13.58-11.34-7.02-6.67
Interest & Investment Income
23.8218.3620.283.980.80.03
Other Non Operating Income (Expenses)
3.68-2.44-0.48-5.1913.8478.12
EBT Excluding Unusual Items
-326.78-265.94-154.66-94.93-71.04-6.55
Merger & Restructuring Charges
---1.6---
Other Unusual Items
---37.2514.19--
Pretax Income
-326.81-265.94-193.51-80.74-71.04-6.55
Net Income
-326.81-265.94-193.51-80.74-71.04-6.55
Net Income to Common
-326.81-265.94-193.51-80.74-71.04-6.55
Net Income Growth
------
Shares Outstanding (Basic)
224187158807776
Shares Outstanding (Diluted)
224187158868382
Shares Change
29.29%18.31%84.90%3.57%0.59%35.24%
EPS (Basic)
-1.46-1.42-1.22-1.01-0.92-0.09
EPS (Diluted)
-1.46-1.42-1.22-1.02-0.97-0.98
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-267.04-216.89-135.97-76.32-63.32-66.74
Free Cash Flow Per Share
-1.19-1.16-0.86-0.89-0.77-0.81
Gross Margin
--292.04%-109.13%-13.51%-12.64%-25.20%
Operating Margin
-680.91%-519.75%-252.47%-140.96%-152.74%-179.31%
Profit Margin
-648.64%-511.90%-303.67%-138.15%-137.95%-15.06%
Free Cash Flow Margin
-530.00%-417.50%-213.37%-130.59%-122.96%-153.36%
EBITDA
-336.26-265.69-157.1-79.4-76.55-75.62
EBITDA Margin
---246.53%-135.86%-148.65%-173.74%
D&A For EBITDA
6.814.323.792.982.112.42
EBIT
-343.07-270.02-160.88-82.38-78.65-78.04
EBIT Margin
---252.47%-140.96%-152.74%-179.31%
Revenue as Reported
50.3851.9563.7258.4451.4943.52
Advertising Expenses
-0.510.920.88--
SEC Filings: 10-K · 10-Q